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In an ancient Egyptian papyrus, dating back to 2500 BC, Imhotep, 
thought to be the first physician and engineer in early history, offers 
us a glimpse into what may have been the earliest recorded case 
of breast cancer.1 When describing this case under ‘Treatment’ he 
suggested, simply: ‘There is none’. It would be another 2 000 years 
before the disease was given a name by Hippocrates who called it 
karkinos, the Greek word for ‘crab’, since the swollen blood vessels 
radiating from a breast tumour resembled the limbs of a crab. In 440 
BC, the historian Herodotus tells the story of Atossa, the queen of 
Persia, who was struck by a malevolent form of cancer, a bleeding 
lump in her breast. In desperation she persuades a slave to take a 
knife and excise the tumour.
In his prize-winning book The Emperor of All Maladies1 Siddhartha 
Mukherjee recounts the history of cancer. The author examines 
cancer with a cellular biologist’s precision, a historian’s perspective, 
and a biographer’s passion. The result is an astonishingly lucid 
and eloquent chronicle of a disease humans have lived with – and 
perished from – for more than 5 000 years. The author challenges 
readers to a thought experiment: imagine Atossa, the Persian queen, 
travelling through time, ‘appearing and reappearing in one age after 
the next’. By freezing her tumour in its stage of development and 
behaviour, Mukherjee asks: ‘How has her treatment changed over 
two-and-a-half millennia and what has been the impact on her 
length of survival?’ From radical mastectomy to radiation by X-rays, 
and from adjuvant chemotherapy to hormonal therapy, he speculates 
that, by the late 20th century, Atossa could reasonably expect to live 
for another 20 years. While the ‘war’ on breast cancer has yet to be 
‘won’, the future is full of possibility. Ultimately, this is a story of hope, 
where a key challenge is early diagnosis and this is where innovative 
engineers have a vital role to play.
Origins of mammography
In November 1895 the physicist Wilhelm Röntgen performed an 
experiment in which invisible cathode rays, generated by electrostatic 
discharges from within an evacuated glass tube, caused a cardboard 
screen to fluoresce.2 He called them X-rays, using the mathematical 
description for something unknown. One of Röntgen’s first X-ray 
images was that of his wife’s hand, and before the year was out – less 
than 2 months later – he had published his groundbreaking article. 
(The peer review process has clearly slowed things down in the 
intervening 117 years.)
Before the middle of 1896 portable X-ray machines, costing just $15 and 
used in conjunction with a photographic plate, were recording images for 
diagnostic purposes all over the world. However, it would be another 60 
years before X-rays were used to diagnose breast cancer. As illustrated by 
an early patent from the 1970s,3 engineers adapted X-ray machines to take 
images of the breast, and the field of mammography was launched. Screen-
film mammography, the use of X-rays and analogue film, has become the 
‘gold standard’ for imaging the breast since then.4
Mammography allows visualisation of soft-tissue abnormalities 
and is able to depict subtle calcifications that may be indicative 
of cancer. Screen-film, however, has several drawbacks: limited 
dynamic range and contrast, granularity and susceptibility to poor 
processing of the photographic film. The past decade has seen 
the emergence of full-field digital mammography (FFDM), which 
captures an electronic image of the X-rays transmitted through the 
breast and is steadily replacing analogue mammography.5 The digital 
mammograms of the left and right breast, in Fig. 1, clearly identify 
the location of a cancerous tumour.
Benefits of slot-scanning X-rays
Twenty years ago De Beers discovered that 10% of its uncut diamonds 
were being stolen by its own workers. With annual sales in excess of 
US$6 billion, this was a significant loss and clearly something had to 
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Aims. While full-field digital mammography has emerged in 
the past decade, this technique suffers from relatively high dose 
levels and poor sensitivity when the breasts are dense. We aimed 
to develop a diagnostic imaging system that exposes the patient to 
lower ionising radiation and improves the sensitivity and specificity 
for women with dense breasts.
Results. Our PantoScanner platform has been designed to 
implement slot scanning digital X-rays, thereby lowering the dose 
and increasing signal-to-noise ratio, while also accommodating 
automated ultrasound and digital tomosynthesis. Early results 
based on mammographic phantoms are encouraging while the 
PantoScanner is undergoing clinical testing prior to commercial 
release.
Conclusion. Since breast cancer kills 500 000 people globally 
every year, early diagnosis by breast screening could save the lives 
of many women. Our fervent hope is that the PantoScanner system 
will significantly contribute to this effort in South Africa and 
around the world.
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be done. Their engineers set about developing a system to screen each 
worker when leaving the mine every day. A key design constraint was 
that no person should be subjected to any physiological harm. Their 
solution was an imaging system based on slot-scanning X-rays that 
produced high-resolution pictures of the whole body at extremely 
low radiation doses.6
But what are slot-scanning X-rays and how can they be used in 
the fight against breast cancer? The first step is to understand how a 
conventional digital X-ray image is acquired. A flat panel detector is a 
rectangular sensor that converts X-rays into an image, similar to that 
of a digital camera. The detector is exposed by the conical beam from 
an X-ray tube for less than a second. In slot scanning, a narrow linear 
image sensor moves in synchrony with an X-ray fan beam. As the 
tungsten blades of a collimator, located just beneath the X-ray tube, 
move from side to side, so the X-ray fan beam sweeps back and forth. 
Image acquisition typically takes about 5 seconds. Slot scanning has 
the major advantage of reducing X-ray scatter, which in turn leads to 
better quality images at lower radiation dose, both key attributes for 
a successful mammography system.7,8
With financial support from the Department of Arts, Culture, 
Science and Technology, the National Institutes of Health9 and 
the Industrial Development Corporation, our engineering team 
set about designing and building a slot scanning digital camera 
for mammography. We now have a state-of-the-art camera called 
the Pandia – named after the Greek goddess of brightness – that 
incorporates advanced attributes. With a pixel size of just 27 
microns, the camera captures an image of 94 megapixels and, with 
a throughput rate of 40 megabytes per second, creates an image 
that is 188 megabytes in size. The Pandia camera has been tested 
on a breast phantom where its ability to detect very fine structures 
indicative of small cancers matches or exceeds all current commercial 
mammography systems that are based on flat-panel detectors. Who 
would have thought that a method to catch diamond thieves could 
impact on our efforts to diagnose breast cancer?
Ultrasound – adding another modality
Medical ultrasound, in which sound waves 100 - 1 000 times higher in 
frequency than those detectable by humans are employed to generate 
images of tissues within the body, has been used in clinical practice 
to detect breast cancer for over half a century.10 Compared with other 
imaging modalities such as digital X-rays and magnetic resonance 
imaging (MRI), ultrasound has several benefits: it is non-invasive, 
inexpensive, portable and has excellent temporal resolution. The basic 
principles of ultrasound are simple: a wave is generated by a transducer 
and propagates through the tissues; the wave is partially reflected at 
the interface between different tissues; the reflection is detected by the 
same transducer; and the time of the reflection, plus the speed of sound 
in the tissue, yields the position of the tissue interface.
Research in the USA shows that in dense breasts, the sensitivity 
(percentage of true positives) increases from 50% to 78% when hand-
held breast ultrasound is added as an adjunct to digital mammography 
in breast screening.11 A recent European study reported that, 
independent of breast density, using an ultrasound machine in addition 
to an X-ray machine, yielded an extra 13% detection of breast cancers.12
A drawback of using hand-held ultrasound machines is that 
the quality and repeatability of the images are highly dependent 
on operator skill. A promising technique that eliminates operator 
dependency is known as automated breast ultrasound. It produces 
3D images with great potential in breast screening. A recent report 
suggests that automated breast ultrasound plus digital mammography 
can double the breast cancer diagnosis detection rate.13
We have invented a method to combine slot scanning X-rays and 
automated breast ultrasound in one device called the PantoScanner 
(Fig. 2 – a drawing from our recent patent application14). Our 
Pandia camera, identified by the number 36, and a custom-designed 
ultrasound probe (number 37) move in synchrony beneath the 
breast. The PantoScanner holds the breast stationary with a standard 
compressor, and can be adjusted for women of different heights, 
including those in a wheelchair. It then rotates 45 degrees from 
the vertical to capture mediolateral oblique images of the left and 
right breasts. Since the ultrasound probe moves beneath the breast 
platform, three-dimensional (3D) ultrasound images can be acquired 
in any orientation.
Tomosynthesis: adding a dimension
A limitation of both screen-film (i.e. analogue) and digital 
mammography is that in a standard 2D projection, healthy and 
Fig. 2. A recent patent application, illustrating how it is possible to combine 
slot-scanning digital X-rays with an automated ultrasound detector.14
Fig. 1. A 46-year-old patient, who denied any lumps or pain in either breast, 
presented for a second opinion. Craniocaudal X-rays of the left and right 
breasts revealed an irregular spiculated mass in the right superior breast, 
although on physical examination no palpable lump was found. These 
images and case study are courtesy of Dr Stamatia Destounis of Elizabeth 
Wende Breast Care in Rochester, New York.
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pathological tissues often overlap. Cancerous lesions can thus be 
hidden, particularly when they are embedded in dense surrounding 
tissues. Digital breast tomosynthesis is a technique in which 10 - 20 
projection views over an arc of about 30 degrees are acquired, and 
then the 3D volume of the breast is reconstructed from the multiple 
2D projections using a mathematical algorithm. 
A benefit of multiple slices of the breast is that the radiologist can 
view them as an animated video sequence. By focusing on the image, 
region by region, the cancerous tumour emerges. We have designed 
our PantoScanner platform so that the tube is able to rotate relative to 
the breast platform (Fig. 2), so that in the future it can accommodate 
the acquisition of tomosynthesis images. One of our engineers has 
also secured a US patent for limited angle tomography.15 Finally, there 
is the promise of combining 3D X-rays and 3D ultrasound.14 So, is 
digital breast tomosynthesis a panacea in breast cancer diagnosis? 
Probably not, but it is a welcome addition to our armamentarium in 
the war on cancer.
Commercialisation – bringing the 
product to market
In mid-2009 we decided the timing was right to spin our company 
out from the University of Cape Town. We believed that a company 
name should have five attributes: linked to our business; enigmatic 
(i.e. there should be a story behind the name); easy to remember; easy 
to spell over the telephone (especially to get e-mail addresses correct); 
and the .com domain name should be available. While we could come 
up with names that met the first four attributes, the availability of 
the .com domain proved elusive. It appeared that every word in the 
English language had been taken by Internet cybersquatters. After 
testing a few hundred names, we came up with one that met all the 
criteria: CapeRay. Our logo was designed around a circle, a universal 
symbol of unity and female power, with our dual-modality concept 
of X-rays and ultrasound represented by the overlapping arcs and 
inward facing waves, respectively.
Concluding remarks
Breast cancer diagnosis is an emotive issue and the benefits of 
breast screening using an advanced imaging technology such 
as digital mammography have been assumed to be self-evident. 
However, a recent paper has questioned the conventional wisdom of 
mammogram breast screening and suggested that the improvements 
in survival have more likely been due to advances in treatment rather 
than regular X-ray machine check-ups.16 Soon after appearing in the 
peer-reviewed scientific literature, it was picked up by lay publications 
such as the Daily Mail in the UK and women understandably 
asked themselves: ‘Will subjecting myself to breast screening via a 
mammogram have any impact on my life expectancy?’ The American 
College of Radiology responded to the article regarding the effect 
of digital mammography screening on breast cancer diagnosis and 
death rates arguing that while improvements in therapy have played 
a role in the decrease in breast cancer deaths, therapy cannot cure 
advanced cancers.
Another recent paper17 has shown that in a study of 133 000 
Swedish women there was a highly significant decrease in breast 
cancer mortality for those receiving a regular breast screening 
mammogram. As Stephen Duffy, a co-author, stated: ‘Everyone must 
make up their own mind, but certainly the combined results from all 
the screening trials [show that] mammography in women aged 40 to 
49 does reduce deaths from breast cancer’.
Data from the National Health Service in Britain show that between 
1971 and 1987 the mortality rate from breast cancer remained 
constant while the incidence steadily increased. After screening 
was introduced in 1988, mortality has steadily decreased, while the 
incidence has continued to increase. Since breast cancer kills 500 000 
people globally every year, early diagnosis by breast screening could 
save many lives. Our fervent hope is that the PantoScanner system 
will make a significant contribution to this effort, in South Africa 
and around the world.
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